Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

NCT03590626 is registered in ClinicalTrials.gov with Medanta, The Medicity, India as lead sponsor.

NCT NCT03590626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03590626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Lead sponsor
Medanta, The Medicity, India
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
February 18, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver disease, type2 diabetes mellitus